Aromatic amino acid metabolism during liver failure

Journal of Nutrition

Volumn 137, Issue 6, 2007, Pages

  Dejong, Cornelis H C ^a   Van De Poll, Marcel C G ^a   Soeters, Peter B ^a   Jalan, Rajiv ^b   Olde Damink, Steven W M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC AMINO ACID; NEUROTRANSMITTER;

ALBUMIN DIALYSIS; BRAIN EDEMA; CATABOLISM; CONFERENCE PAPER; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERAMMONEMIA; LIVER FAILURE; LIVER RESECTION; LIVER WEIGHT; METABOLIC DISORDER; PATHOGENESIS; PORTOSYSTEMIC ANASTOMOSIS; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE;

EID: 34249818790     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/137.6.1579s     Document Type: Conference Paper

References (78)

1. Albrecht J, Jones EA. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J Neurol Sci. 1999;170:138-46.
2. Shawcross D, Jalan R. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell Mol Life Sci. 2005;62:2295-304.
3. Owen OE, Reichle FA, Mozzoli MA, Kreulen T, Patel MS, Elfenbein IB, Golsorkhi M, Chang KH, Rao NS, et al. Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis. J Clin Invest. 1981;68:240-52.
4. Olde Damink SW, Jalan R, Redhead DN, Hayes PC, Deutz NE, Soeters PB. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS. Hepatology. 2002;36:1163-71.
5. Olde Damink SW, Jalan R, Deutz NE, Redhead DN, Dejong CH, Hynd P, Jalan RA, Hayes PC, Soeters PB. The kidney plays a major role in the hyperammonemia seen after simulated or actual GI bleeding in patients with cirrhosis. Hepatology. 2003;37:1277-85.
6. Olde Damink SW, Dejong CH, Deutz NE, Redhead DN, Hayes PC, Soeters PB, Jalan R. The kidney plays a major role in ammonia homeostasis after portasystemic shunting in patients with cirrhosis. Am J Physiol Gastrointest Liver Physiol. 2006;291:189-94.
7. Patel A, van de Poll MC, Greve JW, Buurman WA, Fearon KC, McNally SJ, Harrison EM, Ross JA, Garden OJ, et al. Early stress protein gene expression in a human model of ischemic preconditioning. Transplantation. 2004;78:1479-87.
8. Schindl MJ, Millar AM, Redhead DN, Fearon KC, Ross JA, Dejong CH, Garden OJ, Wigmore SJ. The adaptive response of the reticuloendothelial system to major liver resection in humans. Ann Surg. 2006;243:507-14.
9. Wigmore SJ, Redhead DN, Yan XJ, Casey J, Madhavan K, Dejong CH, Currie EJ, Garden OJ. Virtual hepatic resection using three-dimensional reconstruction of helical computed tomography angioportograms. Ann Surg. 2001;233:221-6.
10. Olde Damink SW, Jalan R, Deutz NE, Dejong CH, Redhead DN, Hynd P, Hayes PC, Soeters PB. (2006) Isoleucine infusion during simulated upper gastrointestinal bleed improves liver and muscle protein synthesis in cirrhotics. Hepatology 2007;45:560-8.
11. James JH, Ziparo V, Jeppsson B, Fischer JE. Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy. Lancet. 1979;2:772-5.
12. Fischer JE, Yoshimura N, Aguirre A, James JH, Cummings MG, Abel RM, Deindoerfer F. Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions. Am J Surg. 1974;127:40-7.
13. Soeters PB, Fischer JE. Insulin, glucagon, aminoacid imbalance, and hepatic encephalopathy. Lancet. 1976;2:880-2.
14. Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery. 1976;80:77-91.
15. Fischer JE, Baldessarini RJ. False neurotransmitters and hepatic failure. Lancet. 1971;2:75-80.
16. Olde Damink SW, Deutz NE, Dejong CH, Soeters PB, Jalan R. Interorgan ammonia metabolism in liver failure. Neurochem Int. 2002;41:177-88.
17. Oldendorf WH, Szabo J. Amino acid assignment to one of three bloodbrain barrier amino acid carriers. Am J Physiol. 1976;230:94-8.
18. Zieve L, Doizaki WM, Derr DF. Reversal of ammonia coma in rats by L-DOPA: a peripheral effect. Gut. 1979;20:28-32.
19. Hagenfeldt L, Eriksson LS, Wahren J. Amino acids in liver disease. Proc Nutr Soc. 1983;42:497-506.
20. Benjamin IS, Engelbrecht GH, Saunders SJ, van Hoorn-Hickman R. Amino acid imbalance following portal diversion in the rat. The relevance of nutrition and of hepatic function. J Hepatol. 1988;7:208-14.
21. de Boer JE, Oostenbroek RJ, van Dongen JJ, Janssen MA, Soeters PB. Sequential metabolic characteristics following portacaval shunt in rats. Eur Surg Res. 1986;18:96-106.
22. Blonde-Cynober F, Aussel C, Cynober L. Abnormalities in branched-chain amino acid metabolism in cirrhosis: influence of hormonal and nutritional factors and directions for future research. Clin Nutr. 1999;18:5-13.
23. Dejong CHC, Kampman MT, Deutz NEP, Soeters PB. Altered glutamine metabolism in rat portal drained viscera during hyperammonemia. Gastroenterology. 1992;102:936-48.
24. Dejong CHC, Kampman MT, Deutz NEP, Soeters PB. Cerebral cortex ammonia and glutamine metabolism during liver insufficiency-induced hyperammonemia in the rat. J Neurochem. 1992;59:1071-9.
25. Dejong CHC, Deutz NEP, Soeters PB. Renal ammonia and glutamine metabolism during liver insufficiency-induced hyperammonemia in the rat. J Clin Invest. 1993;92:2834-40.
26. Dejong CHC, Deutz NEP, Soeters PB. Metabolic adaptation of the kidney to hyperammonemia during chronic liver insufficiency in the rat. Hepatology. 1993;18:890-902.
27. Dejong CHC, Deutz NEP, Soeters PB. Intestinal glutamine and ammonia metabolism during chronic hyperammonaemia induced by liver insufficiency. Gut. 1993;34:1112-9.
28. Dejong CHC, Deutz NEP, Soeters PB. Cerebral cortex ammonia and glutamine metabolism in two rat models of chronic liver insufficiency-induced hyperammonemia: influence of pair feeding. J Neurochem. 1993;60:1047-57.
29. Blonde-Cynober F, Plassart F, Rey C, Coudray-Lucas C, Moukarbel N, Poupon R, Giboudeau J, Cynober L. Assessment of the carbon tetrachloride-induced cirrhosis model for studies of nitrogen metabolism in chronic liver disease. Ann Nutr Metab. 1994;38:238-48.
30. Holmin T, Agardh CD, Alinder G, Herlin P, Hultberg B. The influence of total hepatectomy on cerebral energy state, ammonia-related amino acids of the brain and plasma amino acids in the rat. Eur J Clin Invest. 1983;13:215-20.
31. Knudsen GM, Schmidt J, Almdal T, Paulson OB, Vilstrup H. Passage of amino acids and glucose across the blood-brain barrier in patients with hepatic encephalopathy. Hepatology. 1993;17:987-92.
32. Mattson WJ Jr, Iob V, Sloan M, Coon WW, Turcotte JG, Child CG III. Alterations of individual free amino acids in brain during acute hepatic coma. Surg Gynecol Obstet. 1970;130:263-6.
33. Mans AM, Saunders SJ, Kirsch RE, Biebuyck JF. Correlation of plasma and brain amino acid and putative neurotransmitter alterations during acute hepatic coma in the rat. J Neurochem. 1979;32:285-92.
34. Van de Poll MCG, Luiking YC, Dejong CHC, Soeters PB. (2005) Amino acids: specific functions. In: Caballero B, Allen L, Prentice A, editors. Encyclopedia of human nutrition. 2nd ed. Oxford: Elsevier Ltd; pp. 92-100.
35. Bartelmess P, Bengtsson F, Nobin A, Jeppsson B, Herlin P, Bugge M. The effect of blood ingestion on brain serotonin synthesis in portacavalshunted rats. Res Exp Med (Berl). 1987;187:353-8.
36. Dejong CHC, Meijerink WJHJ, van Berlo CLH, Deutz NEP, Soeters PB. Decreased plasma isoleucine concentrations after upper gastrointestinal haemorrhage in humans. Gut. 1996;39:13-7.
37. Olde Damink SWM, Dejong CHC, Deutz NEP, van Berlo CLH, Soeters PB. Upper gastrointestinal bleeding: an ammoniagenic and catabolic event due to the total absence of isoleucine in the haemoglobin molecule. Med Hypotheses. 1999;52:515-9.
38. van Berlo CLH, van den Boogaard AEJM, van der Heijden MAH, van Eijk HMH, Janssen MA, Bost MCF, Soeters PB. Is increased ammonia liberation after bleeding in the digestive tract the consequence of complete absence of isoleucine in hemoglobin? A study in pigs. Hepatology. 1989;10:315-23.
39. Deutz NEP, Reijven PLM, Bost MCF, van Berlo CLH, Soeters PB. Modification of the effects of blood on amino acid metabolism by intravenous isoleucine. Gastroenterology. 1991;101:1613-20.
40. Jahn HA, Schohn DC, Schmitt RL, Koehl C, Zawislak R, Frick A. Influence of increased plasma ammonium levels on the ratio of plasma to erythrocyte amino acids. Kidney Int Suppl. 1987;22:S197-201.
41. Jessy J, Mans AM, DeJoseph MR, Hawkins RA. Hyperammonaemia causes many of the changes found after portacaval shunting. Biochem J. 1990;272:311-7.
42. Shawcross D, Jalan R. Dispelling myths in the treatment of hepatic encephalopathy. Lancet. 2005;365:431-3.
43. Dejong CHC, Deutz NEP, Soeters PB. Ammonia and glutamine metabolism during liver insufficiency: the role of kidney and brain in interorgan nitrogen exchange. Scand J Gastroenterol. 1996;218:61-77.
44. Welters CFM, Deutz NEP, Dejong CHC, Soeters PB. Enhanced renal vein ammonia efflux after a protein meal in the pig. J Hepatol. 1999;31:489-96.
45. Jalan R, Kapoor D. Enhanced renal ammonia excretion following volume expansion in patients with well compensated cirrhosis of the liver. Gut. 2003;52:1041-5.
46. Dejong CH, Garden OJ. (2003) Neoplasms of the liver. In: Majid AA, Kingsnorth AN, editors. Advanced surgical practice. 1st ed. London: Greenwich Medical Media; pp. 145-156.
47. Wolfe RR. (1992) Radioactive and stable isotope tracers in biomedicine. Principles and practice of kinetic analysis. New York: Wiley-Liss
48. Siroen MP, van der Sijp JR, Teerlink T, van Schaik C, Nijveldt RJ, van Leeuwen PA. The human liver clears both asymmetric and symmetric dimethylarginine. Hepatology. 2005;41:559-65.
49. Watanabe A, Higashi T, Sakata T, Nagashima H. Serum amino acid levels in patients with hepatocellular carcinoma. Cancer. 1984;54:1875-82.
50. Lee JC, Chen MJ, Chang CH, Tiai YF, Lin PW, Lai HS, Wang ST. Plasma amino acid levels in patients with colorectal cancers and liver cirrhosis with hepatocellular carcinoma. Hepatogastroenterology. 2003;50:1269-73.
51. van de Poll MC, Soeters PB, Deutz NE, Fearon KC, Dejong CH. Renal metabolism of amino acids: its role in interorgan amino acid exchange. Am J Clin Nutr. 2004;79:185-97.
52. Dejong CHC, Welters CFM, Deutz NEP, Heineman E, Soeters PB. Renal arginine metabolism in fasted rats with subacute short bowel syndrome. Clin Sci. 1998;95:409-18.
53. Silbernagl S. The renal handling of amino acids and oligopeptides. Physiol Rev. 1988;68:911-1007.
54. Tizianello A, de Ferrari G, Garibotto G, Guerreri G, Robaudo C. Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. J Clin Invest. 1980;65:1162-73.
55. Tizianello A, Deferrari G, Garibotto G, Robaudo C, Salvidio G, Saffiotti S. Renal ammoniagenesis in the postprandial period. Contrib Nephrol. 1985;47:44-57.
56. Moller N, Jensen MD, Rizza RA, Andrews JC, Nair KS. Renal amino acid, fat and glucose metabolism in type 1 diabetic and non-diabetic humans: effects of acute insulin withdrawal. Diabetologia. 2006;49:1901-8.
57. Moller N, Meek S, Bigelow M, Andrews J, Nair KS. The kidney is an important site for in vivo phenylalanine-to-tyrosine conversion in adult humans: a metabolic role of the kidney. Proc Natl Acad Sci USA. 2000;97:1242-6.
58. Lichter-Konecki U, Hipke CM, Konecki DS. Human phenylalanine hydroxylase gene expression in kidney and other nonhepatic tissues. Mol Genet Metab. 1999;67:308-16.
59. Tessari P, Deferrari G, Robaudo C, Vettore M, Pastorino N, De Biasi L, Garibotto G. Phenylalanine hydroxylation across the kidney in humans. Kidney Int. 1999;56:2168-72.
60. Rose WC, Oesterling MJ, Womack M. Comparative growth on diets containing ten and nineteen amino acids, with further observations on the role of glutamic and aspartic acids. J Biol Chem. 1948;176:753-62.
61. Rose WC. Nutrition classics. Federation Proceedings 8(2)546-52, June 1949. Amino acid requirements of man. William C. Rose. Nutr Rev.1976;34:307-9.
62. Boirie Y, Albright R, Bigelow M, Nair KS. Impairment of phenylalanine conversion to tyrosine in end-stage renal disease causing tyrosine deficiency. Kidney Int. 2004;66:591-6.
63. Young GA, Parsons FM. Impairment of phenylalanine hydroxylation in chronic renal insufficiency. Clin Sci. 1973;45:89-97.
64. Garibotto G, Deferrari G, Robaudo C, Saffioti S, Paoletti E, Pontremoli R, Tizianello A. Effects of a protein meal on blood amino acid profile in patients with chronic renal failure. Nephron. 1993;64:216-25.
65. Pickford JC, McGale EH, Aber GM. Studies on the metabolism of phenylalanine and tyrosine in patients with renal disease. Clin Chim Acta. 1973;48:77-83.
66. Garibotto G, Tessari P, Verzola D, Dertenois L. The metabolic conversion of phenylalanine into tyrosine in the human kidney: does it have nutritional implications in renal patients? J Ren Nutr. 2002;12:8-16.
67. Garibotto G. Muscle amino acid metabolism and the control of muscle protein turnover in patients with chronic renal failure. Nutrition. 1999;15:145-55.
68. Druml W, Roth E, Lenz K, Lochs H, Kopsa H. Phenylalanine and tyrosine metabolism in renal failure: dipeptides as tyrosine source. Kidney Int Suppl. 1989;27:S282-6.
69. Abitbol CL, Mandel S, Mrozinska K, Wapnir RA. Tyrosine supplementation in chronic experimental uremia. Biochem Med. 1983;30:101-10.
70. van Eijk HMH, Dejong CHC, Deutz NEP, Soeters PB. Influence of storage conditions on normal plasma amino-acid concentrations. Clin Nutr. 1994;13:374-80.
71. Loock J, Mitzner SR, Peters E, Schmidt R, Stange J. Amino acid dysbalance in liver failure is favourably influenced by recirculating albumin dialysis (MARS). Liver. 2002;22 Suppl 2:35-9.
72. Tan HK. Molecular adsorbent recirculating system (MARS). Ann Acad Med Singapore. 2004;33:329-35.
73. Awad SS, Swaniker F, Magee J, Punch J, Bartlett RH. Results of a phase I trial evaluating a liver support device utilizing albumin dialysis. Surgery. 2001;130:354-62.
74. Mitzner S, Loock J, Peszynski P, Klammt S, Majcher-Peszynska J, Gramowski A, Stange J, Schmidt R. Improvement in central nervous system functions during treatment of liver failure with albumin dialysis MARS: a review of clinical, biochemical, and electrophysiological data. Metab Brain Dis. 2002;17:463-75.
75. Steczko J, Bax KC, Ash SR. Effect of hemodiabsorption and sorbent-based pheresis on amino acid levels in hepatic failure. Int J Artif Organs. 2000;23:375-88.
76. Boyle M, Kurtovic J, Bihari D, Riordan S, Steiner C. Equipment review: the molecular adsorbents recirculating system (MARS). Crit Care. 2004;8:280-6.
77. James JH, Herlin PM, Edwards L, Nachbauer CA, Fischer JE. Effect of infusing the branched-chain amino acids on concentrations of amino acids in plasma and brain and on brain catecholamines after total hepatectomy in the rat. Life Sci. 1982;30:1361-8.
78. Charlton M. Branched-chain amino acid enriched supplements as therapy for liver disease. J Nutr. 2006;136:S295-8.